Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Hereditary Parkinson s Disease Natural History Protocol

View source ↗

Summary

NHLBI-sponsored hereditary Parkinson disease natural history protocol completed, outlining observational study design for early-onset and familial genetic forms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Parkinson Disease 6, Early-Onset, Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Status: COMPLETED